CSHL Settles Patent Malpractice Dispute with Former IP Counsel | GenomeWeb

NEW YORK (GenomeWeb) – Marking the end of years of litigation, Cold Spring Harbor Laboratory (CSHL) announced this week that it has settled its patent malpractice lawsuit against its former patent counsel just days before the case was set to go to jury trial.

The specific terms of the settlement are not being made public, a CSHL spokesperson told Gene Silencing News. However, the spokesperson said that CSHL will receive a cash payout "in the millions" and that the institution is pleased with the outcome.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.